Riyadh — Mubasher: Jana Medical Company has formed its Audit Committee for a new four-year term following a board of directors meeting held on 12 November, according to a bourse disclosure.
The committee’s tenure officially commenced on 10 November 2026 and is scheduled to conclude on 9 November 2030, aligning with the current board’s session.
The board appointed Eyad Issa Abed, an external member, as the chairman of the committee, who brings over 30 years of experience in financial management and strategy.
Joining Abed are independent members Abdullah bin Ismail bin Abdullah Al Khatib, a legal expert with 15 years of experience in corporate law and governance, and Haroun Rashid Rabah Abu Shehadeh, who holds a doctorate in business process re-engineering and possesses 25 years of leadership experience in institutional development.
The appointments were finalized during the board's first meeting of the new cycle.
Meanwhile, the committee is tasked with overseeing the company’s internal controls, risk management frameworks, and financial reporting processes throughout the four-year duration of its mandate.